Molecular modelling is a widely used tool in the field of pharmaceutical industries and chemistry for the drug development. It investigate, interpret, explain, and discover new phenomenon of molecules. The Global Molecular Modelling Market is expected to grow at a CAGR of ~ 15.4% during the forecast period 2017-2023.
Molecular Modelling Market – Key Players
Some of key players in the market are:
- Fisher Scientific Company LLC. (US)
- Indigo Instruments (US)
- Simulation Plus (US)
- Certara, L.P. (US)
- Dassault Systèmes (France)
- Advanced Chemistry Development (Canada)
- Schrödinger LLC (US)
- Genedata AG (Switzerland)
- Chemical Computing Group ULC (Canada)
- Physiomics PLC (UK)
- Entelos, Inc. (US)
Click to Get Sample Report @ https://www.marketresearchfuture.com/sample_request/4330 .
Molecular Modelling Market – Overview
Molecular modeling has become a valuable and essential tool in the medicinal chemistry for the drug design process. It describes generation, manipulation or representation of three-dimensional structures of molecules and their associated physic-chemical properties. The method is used in drug design, computational biology, computational chemistry, and materials science. It involves wide range of computerized techniques based on theoretical chemistry methods and experimental data to analyze the biological and molecular property.
The major driving factors for the market are increasing investments in R&D, increasing prevalence of chronic diseases, and increasing demand for the better treatment. According to the World Health Organization (WHO), chronic diseases are the leading cause of mortality across the world, representing around 60% of all deaths. Molecular modeling is easy to perform with currently available software, but it is difficult get right model and proper interpretation.
Changing lifestyle and increasing geriatric population have increased the probability of causing the different diseases. In addition to this, technological advancements, increasing need for the cost-effective treatment and growth in the biology and biosimilars markets have fuelled the market growth. However, high cost of the research and limited availability of skilled professional may affect the growth of the market over the assessment period, negetively.
Molecular Modelling Market – Regional Analysis
The Americas dominates the global molecular modelling market owing to the presence of huge patient population, high healthcare spending, and increasing government support for research & development. Europe is the second largest global molecular modelling market followed by Asia Pacific. The growth of the European market is majorly attributed to the increasing government support, and high healthcare spending.
Asia Pacific is the fastest growing molecular modelling market. Japan holds the major share of the regional market. Whereas, China and India are the fastest growing market due to rapidly growing economy, increasing healthcare expenditure, and government initiatives for research & development.
The Middle East & Africa holds the least share of the global market due to limited availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market. Whereas, the African region is expected to witness a moderate growth.
Molecular Modelling Market – Intended Audience
- Pharmaceutical Companies
- Research and Development (R&D) Companies
- Biotechnological Companies
- Hospitals and Clinics
- Academic Institutes and Universities
Get Unbelievable Discount on Report @ https://www.marketresearchfuture.com/check-discount/4330
Molecular Modelling Market – Segmentation
The global molecular modelling market has been segmented on the basis of approach, application, product, and end user.
On the basis of approach, the market is segmented into molecular mechanics approach, and quantum chemistry approach.
On the basis of product, the market is segmented into instruments, reagents, kits, and others.
On the basis of application, the market is segmented into drug development, drug discovery, and other application. Drug discovery is further segmented into direct drug design, indirect drug design, and molecular mimicry. The direct drug design is sub-segmented into lead identification, target identification, and others. Indirect drug design is sub-segmented into pharmacophore, quantitative structure-activity relationships (QSAR), and others.
On the basis of end user, the market is segmented into pharmaceutical & biotechnological companies, research organizations, and others
Brief Table of Content
1 Report Prologue
2 Market Introduction
2.2 Scope of the Study
2.2.1 Research Objective
3 Research Methodology
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4 Market Dynamics
To Know More Enquire @ https://www.marketresearchfuture.com/enquiry/4330 .
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312